Benefit of Renin Angiotensin Aldosterone Blockade in Kidney Transplant Recipients: Is the Verdict in or Still to Be Answered?

Clin J Am Soc Nephrol. 2024 Jun 1;19(6):691-693. doi: 10.2215/CJN.0000000000000479. Epub 2024 May 17.

Authors

Deirdre Sawinski^{1

2}, Amy K Mottl³

Affiliations

¹ Division of Nephrology and Hypertension, Department of Medicine, Weill Cornell Medical College, New York, New York.
² Department of Transplantation Medicine, New York-Presbyterian/Weill Cornell Medical Center, New York, New York.
³ University of North Carolina Kidney Center, UNC School of Medicine at Chapel Hill, Chapel Hill, North Carolina.

PMID: 38758607
DOI: 10.2215/CJN.0000000000000479

No abstract available

MeSH terms

Angiotensin Receptor Antagonists / therapeutic use
Angiotensin-Converting Enzyme Inhibitors* / therapeutic use
Humans
Kidney Transplantation*
Mineralocorticoid Receptor Antagonists / therapeutic use
Renin-Angiotensin System* / drug effects
Treatment Outcome

Substances

Angiotensin-Converting Enzyme Inhibitors
Mineralocorticoid Receptor Antagonists
Angiotensin Receptor Antagonists